CO-FUNDED BY THE FONDS QUÉBÉCOIS DE LA RECHERCHE SUR LA NATURE ET LE LES TECHNOLOGIES (FRQNT)
Many pharmaceutical compounds used to treat disease and promote health of livestock are protein in composition. They are typically manufactured using cell lines, cultivated under controlled environment with complex nutrients that are expensive to operate.
We propose to use available genomics knowledge and genetic engineering technologies to construct a low-cost and high-yield cell factory to manufacture therapeutics that are used in livestock. We expect the cost of manufacturing high-value therapeutics using this advanced cell factory to drop by a minimum of 90% compared to current manufacturing systems.
Québec is the largest producer of dairy and pork and the second largest producer of poultry in Canada. Much of the cost savings in manufacturing pharmaceutical compounds will be passed on to the customers, the livestock producers. The reduction in livestock production cost will in turn lead to lower food price for the consumers. Healthy livestock also has the potential of reducing the risk of disease spread.
Genome Centre: Génome Québec
User:
| Jen | Chmielowski | Kemin Industries, Inc. |